Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold Lee

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Drugs|July 30, 2025
Senaparib: First ApprovalArnold Lee
Drugs|July 30, 2025
Acoltremon: First ApprovalArnold Lee
Drugs|June 23, 2025
Limertinib: First ApprovalArnold Lee
Drugs|April 1, 2025
Cosibelimab: First ApprovalArnold Lee
Molecular Diagnosis & Therapy|August 28, 2025
Prademagene Zamikeracel: First ApprovalArnold Lee
Drugs|August 29, 2025
Linvoseltamab: First ApprovalArnold Lee
Drugs|November 26, 2021
Avacopan: First ApprovalArnold Lee
Targeted Oncology|April 19, 2022
Correction to: MYL-1402O: A Bevacizumab BiosimilarArnold Lee
Targeted Oncology|September 16, 2023
Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate CancerArnold Lee
Drugs|November 12, 2025
Elinzanetant: First ApprovalArnold Lee
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Drugs|July 30, 2025
Senaparib: First ApprovalArnold Lee
Drugs|July 30, 2025
Acoltremon: First ApprovalArnold Lee
Drugs|June 23, 2025
Limertinib: First ApprovalArnold Lee
Drugs|April 1, 2025
Cosibelimab: First ApprovalArnold Lee
Molecular Diagnosis & Therapy|August 28, 2025
Prademagene Zamikeracel: First ApprovalArnold Lee
Drugs|August 29, 2025
Linvoseltamab: First ApprovalArnold Lee
Drugs|November 26, 2021
Avacopan: First ApprovalArnold Lee
Targeted Oncology|April 19, 2022
Correction to: MYL-1402O: A Bevacizumab BiosimilarArnold Lee
Targeted Oncology|September 16, 2023
Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate CancerArnold Lee
Drugs|November 12, 2025
Elinzanetant: First ApprovalArnold Lee
Pageof 10